Xitandi 40MG gcap 120S
Ended Awarded
- Contract number
- SPE2DR26FBSZY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,669
Award facts
- Contract value 100% obligated
- $17,669.25 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $17,669.25 to DMS Pharmaceutical Group Inc. for XITANDI 40MG GCAP 120S, a specialty pharmaceutical product. The award was made on October 27, 2025, with an ultimate completion date of the same date, and carries no set-aside designation, indicating the contractor competed in an unrestricted procurement environment. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical support to Department of Defense military healthcare facilities worldwide. The underlying IDC, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for branded and generic prescription medications, biologics, and medical consumables. DMS Pharmaceutical Group's established performance across numerous delivery orders and its certification as a critical supplier within the federal pharmaceutical supply chain position it as a key provider within this strategic military medical supply program.
Quick answers
Who was awarded contract SPE2DR26FBSZY?
SPE2DR26FBSZY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DR26FBSZY worth?
The government has obligated $17,669 on SPE2DR26FBSZY.
Is contract SPE2DR26FBSZY an order under another contract?
Yes. SPE2DR26FBSZY is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBSZY competed?
The extent of competition for SPE2DR26FBSZY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award